Reducing the Burden of Preeclampsia RFP
This grant funds innovative research to develop new methods for early detection, prevention, and treatment of preeclampsia, focusing on solutions suitable for low- and middle-income countries.
This grant is no longer accepting proposals
Bill and Melinda Gates Foundation has archived this opportunity.
Funder: Bill and Melinda Gates Foundation
Due Dates: March 25, 2025: Full application submission deadline (Applications due no later than 11:30 a.m. US Pacific Time)
Funding Amounts: Up to $500,000 USD per project | Grant term up to 2 years | Indirect costs allowed (per Gates Foundation policy)
Summary: Supports innovative research for early detection, prevention, and treatment of preeclampsia, especially in low- and middle-income countries.
Key Information: Implementation science proposals are not eligible; focus is on discovery and solutions adaptable to LMICs.
Description
This funding opportunity seeks proposals for innovative solutions to reduce the global burden of preeclampsia, a leading cause of maternal and neonatal morbidity and mortality. The focus is on early detection, prevention, and treatment approaches that are adaptable and scalable for low- and middle-income countries (LMICs) with high maternal mortality rates. The grant encourages collaborative, cross-sector projects that advance novel biomarkers, diagnostic technologies, mechanistic understanding, and new preventive or therapeutic interventions. The goal is to support practical, impactful research that can be deployed in resource-limited settings.
